CELMOD Trademark

Trademark Overview

On Tuesday, February 3, 2015, a trademark application was filed for CELMOD with the United States Patent and Trademark Office. The USPTO has given the CELMOD trademark a serial number of 86522485. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Wednesday, May 18, 2022. This trademark is owned by Celgene Corporation. The CELMOD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation
celmod

General Information

Serial Number86522485
Word MarkCELMOD
Filing DateTuesday, February 3, 2015
Status710 - CANCELLED - SECTION 8
Status DateWednesday, May 18, 2022
Registration Number4825958
Registration DateTuesday, October 6, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateWednesday, May 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Thursday, May 19, 2022NOTICE OF CANCELLATION SEC. 8 EMAILED
Wednesday, May 18, 2022CANCELLED SEC. 8 (6-YR)
Monday, October 18, 2021OFFICE ACTION ISSUED POU1
Friday, October 15, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 6, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 6, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 5, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 4, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, June 4, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 4, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, June 4, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, June 4, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 4, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 28, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, April 16, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 16, 2015LETTER OF SUSPENSION E-MAILED
Thursday, April 16, 2015SUSPENSION LETTER WRITTEN
Wednesday, April 15, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 15, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 14, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 8, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 8, 2015NON-FINAL ACTION E-MAILED
Wednesday, April 8, 2015NON-FINAL ACTION WRITTEN
Wednesday, April 1, 2015ASSIGNED TO EXAMINER
Monday, February 23, 2015PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, February 13, 2015ASSIGNED TO LIE
Thursday, February 12, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 6, 2015TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, February 6, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

celmod disease fields skin diseases oncology inflammation immunology musculoskeletal cancer treatment